Neoplasms, Lung: Clinical Trials

1 trial for Neoplasms, Lung, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Neoplasms, Lung: new trials by email Literature Review of Neoplasms, Lung trials Research Report on Neoplasms, Lung

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
talabostat, pemetrexed - Carcinoma, Non-Small-Cell Lung, Lung Cancer
Phase 3TerminatedPoint Therapeutics4002006-02-012007-06-08

Narrower conditions

Carcinoma, Non-Small-Cell Lung (1)  ·  Lung Neoplasms (1)

Broader conditions

Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Lung Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Neoplasms (1)  ·  Thoracic Neoplasms (1)

Interventions

Pemetrexed (1)  ·  talabostat (1)

Sponsors

Point Therapeutics (1)

Countries

United States (1)